OVID THERAPEUTICS INC
OVIDNASDAQ🏆 #2720 by market capEarnings Aug 18US Equity
$2.59▲ $0.02 (+0.58%)
Live1h▲ 0.2%
24h▲ 0.6%
7d▼ 0.6%
14d▲ 13.3%
30d▲ 7.0%
1y▲ 376.7%
🏦Market Cap
$484M
Small Cap
📈Revenue Growth (YoY)
+1199.6%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
65.8x
Expensive
Otter Score
59
Weak
📊
Analyst Ratings
Price
$2.59
Total
14
Raised
0
Lowered
2
Avg PT
$5.50
H / L
$7 / $4
| Institution | Action | Rating | Date |
|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-08-03 |
Wedbush | Reiterated | Outperform | 2026-04-15 |
HC Wainwright & Co. | Reiterated | Buy | 2026-04-09 |
BTIG | Reiterated | Buy | 2026-03-26 |
Citigroup | Reiterated | Neutral | 2024-06-18 |
B. Riley Securities | Reiterated | Buy | 2024-06-18 |
Ladenburg Thalmann | Reiterated | Buy | 2023-05-02 |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2021-04-20 |
JMP Securities | Downgraded | Market Outperform → Market Perform | 2020-12-02 |
Citi | Reiterated | Buy | 2019-09-24 |
RBC Capital | Reiterated | Outperform | 2019-09-04 |
PiperJaffray | Reiterated | Overweight | 2018-03-09 |
William Blair | Reiterated | Outperform | 2017-05-30 |
Cowen & Co. | Reiterated | Outperform | 2017-05-30 |
One row per institution, most recent rating